Global Monoclonal Antibody Therapy Market Size, Status and Forecast 2019-2025
Table of Content
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Monoclonal Antibody Therapy Revenue
- 1.4 Market by Type
- 1.4.1 Global Monoclonal Antibody Therapy Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Recombinant
- 1.4.3 Chimeric
- 1.4.4 Humanized
- 1.4.5 Human
- 1.5 Market by Application
- 1.5.1 Global Monoclonal Antibody Therapy Market Share by Application: 2020 VS 2026
- 1.5.2 Diagnostic Test
- 1.5.3 Analytical And Chemical Uses
- 1.5.4 Cancer Treatment
- 1.5.5 Autoimmune Diseases
- 1.5.6 Hematological Disorders
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Global Monoclonal Antibody Therapy Market Perspective (2015-2026)
- 2.2 Global Monoclonal Antibody Therapy Growth Trends by Regions
- 2.2.1 Monoclonal Antibody Therapy Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Monoclonal Antibody Therapy Historic Market Share by Regions (2015-2020)
- 2.2.3 Monoclonal Antibody Therapy Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Monoclonal Antibody Therapy Market Growth Strategy
- 2.3.6 Primary Interviews with Key Monoclonal Antibody Therapy Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Monoclonal Antibody Therapy Players by Market Size
- 3.1.1 Global Top Monoclonal Antibody Therapy Players by Revenue (2015-2020)
- 3.1.2 Global Monoclonal Antibody Therapy Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Monoclonal Antibody Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Monoclonal Antibody Therapy Market Concentration Ratio
- 3.2.1 Global Monoclonal Antibody Therapy Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Therapy Revenue in 2019
- 3.3 Monoclonal Antibody Therapy Key Players Head office and Area Served
- 3.4 Key Players Monoclonal Antibody Therapy Product Solution and Service
- 3.5 Date of Enter into Monoclonal Antibody Therapy Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Monoclonal Antibody Therapy Historic Market Size by Type (2015-2020)
- 4.2 Global Monoclonal Antibody Therapy Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
- 5.1 Global Monoclonal Antibody Therapy Market Size by Application (2015-2020)
- 5.2 Global Monoclonal Antibody Therapy Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Monoclonal Antibody Therapy Market Size (2015-2020)
- 6.2 Monoclonal Antibody Therapy Key Players in North America (2019-2020)
- 6.3 North America Monoclonal Antibody Therapy Market Size by Type (2015-2020)
- 6.4 North America Monoclonal Antibody Therapy Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Monoclonal Antibody Therapy Market Size (2015-2020)
- 7.2 Monoclonal Antibody Therapy Key Players in Europe (2019-2020)
- 7.3 Europe Monoclonal Antibody Therapy Market Size by Type (2015-2020)
- 7.4 Europe Monoclonal Antibody Therapy Market Size by Application (2015-2020)
8 China
- 8.1 China Monoclonal Antibody Therapy Market Size (2015-2020)
- 8.2 Monoclonal Antibody Therapy Key Players in China (2019-2020)
- 8.3 China Monoclonal Antibody Therapy Market Size by Type (2015-2020)
- 8.4 China Monoclonal Antibody Therapy Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Monoclonal Antibody Therapy Market Size (2015-2020)
- 9.2 Monoclonal Antibody Therapy Key Players in Japan (2019-2020)
- 9.3 Japan Monoclonal Antibody Therapy Market Size by Type (2015-2020)
- 9.4 Japan Monoclonal Antibody Therapy Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Monoclonal Antibody Therapy Market Size (2015-2020)
- 10.2 Monoclonal Antibody Therapy Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Monoclonal Antibody Therapy Market Size by Type (2015-2020)
- 10.4 Southeast Asia Monoclonal Antibody Therapy Market Size by Application (2015-2020)
11 India
- 11.1 India Monoclonal Antibody Therapy Market Size (2015-2020)
- 11.2 Monoclonal Antibody Therapy Key Players in India (2019-2020)
- 11.3 India Monoclonal Antibody Therapy Market Size by Type (2015-2020)
- 11.4 India Monoclonal Antibody Therapy Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Monoclonal Antibody Therapy Market Size (2015-2020)
- 12.2 Monoclonal Antibody Therapy Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Monoclonal Antibody Therapy Market Size by Type (2015-2020)
- 12.4 Central & South America Monoclonal Antibody Therapy Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Abbvie
- 13.1.1 Abbvie Company Details
- 13.1.2 Abbvie Business Overview
- 13.1.3 Abbvie Monoclonal Antibody Therapy Introduction
- 13.1.4 Abbvie Revenue in Monoclonal Antibody Therapy Business (2015-2020))
- 13.1.5 Abbvie Recent Development
- 13.2 Amgen
- 13.2.1 Amgen Company Details
- 13.2.2 Amgen Business Overview
- 13.2.3 Amgen Monoclonal Antibody Therapy Introduction
- 13.2.4 Amgen Revenue in Monoclonal Antibody Therapy Business (2015-2020)
- 13.2.5 Amgen Recent Development
- 13.3 Glaxosmithkline
- 13.3.1 Glaxosmithkline Company Details
- 13.3.2 Glaxosmithkline Business Overview
- 13.3.3 Glaxosmithkline Monoclonal Antibody Therapy Introduction
- 13.3.4 Glaxosmithkline Revenue in Monoclonal Antibody Therapy Business (2015-2020)
- 13.3.5 Glaxosmithkline Recent Development
- 13.4 Merck
- 13.4.1 Merck Company Details
- 13.4.2 Merck Business Overview
- 13.4.3 Merck Monoclonal Antibody Therapy Introduction
- 13.4.4 Merck Revenue in Monoclonal Antibody Therapy Business (2015-2020)
- 13.4.5 Merck Recent Development
- 13.5 Novartis
- 13.5.1 Novartis Company Details
- 13.5.2 Novartis Business Overview
- 13.5.3 Novartis Monoclonal Antibody Therapy Introduction
- 13.5.4 Novartis Revenue in Monoclonal Antibody Therapy Business (2015-2020)
- 13.5.5 Novartis Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Description
Monoclonal Antibody Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Monoclonal Antibody Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbvie
Amgen
Glaxosmithkline
Merck
Novartis
...
Market segment by Type, the product can be split into
Recombinant
Chimeric
Humanized
Human
Market segment by Application, split into
Diagnostic Test
Analytical And Chemical Uses
Cancer Treatment
Autoimmune Diseases
Hematological Disorders
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America